BDX Q4 2023 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.1B+6.8% YoY

Gross Profit

$1.7B33.4% margin

Operating Income

$349M6.9% margin

Net Income

$108M2.1% margin

EPS (Diluted)

$0.37

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.0B

Stock-Based Comp.

$58M

Balance Sheet

Total Assets

$52.8B

Total Liabilities

$27.0B

Stockholders' Equity

$25.8B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.1B	$4.8B	+6.8%
Gross Profit	$1.7B	$2.1B	-18.1%
Operating Income	$349M	$489M	-28.6%
Net Income	$108M	$288M	-62.5%

Revenue Segments

Medical

$2.6B50%

Life Sciences

$1.3B26%

Interventional

$1.2B24%

Geographic Segments

UNITED STATES

$2.9B57%

Non-US

$2.2B43%